Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Eisai to Present E7386, co-created by PRISM BioLab and Eisai, at the ESMO (European Society for Medical Oncology) Annual Meeting
-
Teledyne FLIR Delivering Airborne Surveillance Systems to Japan Maritime Self-Defense Force Worth Up to $21 Million
-
HUTCHMED Highlights Clinical Data to be Presented at ESMO Congress 2024 and the 2024 World Conference of Lung Cancer
-
Hoonigan Signs Asset Purchase Agreement to Divest 4 Wheel Parts’ Retail Stores and Associated E-Commerce Assets to ARB Corporation’s U.S. Affiliate, ORW USA
-
Hoonigan Announces Strategic Transaction to Strengthen Financial Foundation and Support Long-Term Growth
-
Collaboration between China, Africa helps foster a more just global order
-
Toshiba Unveils the High-End Masterstroke Series at IFA 2024, Showcasing a New Era of Masterpiece Appliances
-
The 2024 Global Energy Transition Conference Kicks Off in Beijing's Future Science City
-
Saudi Arabia's landmark Global AI Summit to address harnessing AI for the good of humanity
-
MacroGenics Announces TAMARACK Phase 2 Data Presentation at ESMO Congress 2024
-
What’s New with Personio: Improved people insights, performance reviews and custom workflows drive impact for HR teams
-
NOVONIX Announces Participation in the H.C. Wainwright Conference
-
ALIMENTATION COUCHE-TARD COMMENTS ON SEVEN & I HOLDINGS' RESPONSE NOT TO ENGAGE IN FRIENDLY DISCUSSIONS REGARDING A VALUE CREATING COMBINATION
-
Cantargia: New Data from Two Clinical Studies Strongly Support Nadunolimab Efficacy After Relapse on PD1-Inhibitors
-
Ultimovacs Announces Updated Data Analysis on UV1 Phase II NIPU Trial in Mesothelioma at ESMO 2024
-
C4 Therapeutics to Present Preliminary CFT1946 Monotherapy Phase 1 Clinical Data at the European Society for Medical Oncology (ESMO) Congress 2024
-
Avacta to present updated clinical data on AVA6000 at the European Society for Medical Oncology (ESMO) Congress
-
Resecurity Partners with Mannai Trading Corporation to Bolster Cybersecurity in Qatar
-
ICEYE to deliver SAR satellites and data to Greece's National Satellite Space Project in collaboration with the European Space Agency
-
Perioperative Ivonescimab (PD-1/VEGF) for NSCLC Demonstrated Clinically Significant Phase II Results, Presented in Oral Session at WCLC 2024
-
LinkBuilder.io Analyzes Impact of Google's SpamBrain Link Update
-
Government Leaders to Detail Patient Harm Prevention Efforts at World Patient Safety Day Summit
-
RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE™ (lazertinib) show strong favorable overall survival trend versus osimertinib in EGFR-mutated advanced lung cancer
-
Law Office of Gerald Marcus Selected to Super Lawyers 2025 for the 11th Year Running
-
Feldman Immigration Lawyers Marks 15 Years of Legal Excellence in US Immigration Landscape
-
Davis Bucco & Makara Lawyers Continue Streak of Winning the Super Lawyers Selection for Eight Consecutive Years
-
Third Consecutive Year: Mottaz & Sisk Work Injury Lawyers Named 2024’s Top Workers’ Compensation Attorneys in Coon Rapids, Minnesota by Super Lawyers
-
Grateful Earth Expands Mushroom Coffee Line, Revolutionizing Mornings With Brain-Healthy Superfoods
-
Wellmade Launches Ashbury ADUs, Expanding its Line of Modern Prefab Living Spaces
-
AdvisorVault's 17a-4 Managed 365 Service: Finally, Guaranteed FINRA Compliance On The Microsoft Cloud
-
Novel Computational Pathology-Based TROP2 Biomarker for Datopotamab Deruxtecan Was Predictive of Clinical Outcomes in Patients with Non-Small Cell Lung Cancer in TROPION-Lung01 Phase 3 Trial
-
Novel computational pathology-based TROP2 biomarker for datopotamab deruxtecan was predictive of clinical outcomes in patients with non-small cell lung cancer in TROPION-Lung01 Phase III trial
-
Akeso's Ivonescimab Head-to-Head Phase III Data Against Pembrolizumab Unveiled at WCLC 2024
-
Kendrick Lamar to Perform at Apple Music Super Bowl LIX Halftime Show Sunday, February 9, 2025, on FOX
-
Summit (SMMT): Ivonescimab Monotherapy Reduced Risk of Disease Progression or Death by 49% Compared to Pembrolizumab Monotherapy in First-Line Treatment of Patients with PD-L1 Positive Advanced NSCLC
-
Coalition Announces Reinsurance Intermediary Coalition Re
-
Cregis Embarks on a Global Journey to Build the Leading Brand in Digital Asset Infrastructure Services
-
Elis to host a webcast as part of non-deal roadshow
-
Announcing a New Shark Fishing Experience in Panama City Beach with Kelley Girl Charters
-
Experience the Future of Yard Maintenance with MAMMOTION's Robotic Lawn Mowers at IFA 2024
-
Avalyn Presents Multiple Posters on AP01 for Pulmonary Fibrosis, Including MIST Phase 2b Trial Design and ATLAS Phase 1b Study Post-hoc Analyses, at ERS 2024
-
Leap4 Integrates The Media Sense Into Its Growing Streaming and Ad Tech Offering
-
World Polo League and Global Child team up for "Travel & Purpose" Palm Beach
-
SUR-FURS PREPPED TO FETCH TOP HONORS AT HELEN WOODWARD ANIMAL CENTER'S 19TH ANNUAL SURF DOG SURF-A-THON
-
Savara Announces New Data from Pivotal Phase 3 IMPALA-2 Trial of Molgramostim Nebulizer Solution (Molgramostim) in Patients with Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Were Presented at the
-
Longboard Pharmaceuticals Announces Positive Interim Analysis Results from the Open-Label Extension (OLE) of the Phase 1b/2a PACIFIC Study Evaluating Bexicaserin in Participants with Developmental and
-
Midea Flexify French Door Air Fryer Oven Shine at IFA 2024: Versatility and Convenience Meets Sleek Design
-
Global Times: Silk Road Maritime Cooperation Forum kicks off in China's Xiamen, to facilitate international ocean shipping, trade
-
Hong Kong Watch & Clock Fair, Salon de TIME conclude successfully
-
TECNO Unveils the MEGABOOK K16S at IFA 2024: The best cost-performance laptop in its class.
